BNET Industries
Medtronic Inc. (MDT) is in the Health Care Industry
Latest News and Analysis
Medtronic Accuses NuVasive of Patent Infringement
Douglas Cress submits: Device giant Medtronic MDT Sofamor Danek has filed a complaint against NuVasive NUVA, alleging patent infringement by certain NuVasive products. NuVasive is in the process of reviewing the complaint and assessing its defenses. Based on an initial review, Alex Lukianov, the company’s Chairman and CEO, does...
Medtronics: Even More Good News
Eddy Elfenbein submits: This morning, Medtronic MDT posted adjusted fiscal first-quarter earnings of 72 cents a share which topped Wall Street’s forecast of 69 cents a share. For last year’s Q1, the company earned an adjusted 62 cents a share, so that’s an impressive increase. Revenues rose 18.5% to...
Earnings Preview: Medtronics
Medtronic MDT is expected to report Q1 earnings before the bell Tuesday, Aug. 19, with a conference call scheduled for 8:00 am ET. Guidance Analysts are looking for a profit of 69c on revenue of $3.67B. The consensus is 67c to 72c for EPS, and revenue of $3.58B to $3.73B,...
Companies With Recent, Innovative Product Approvals vs. Healthcare ETFs
Mike Havrilla submits: The table below presents a global index of healthcare companies that have received FDA approval for innovative products in the last 12 months. The index excludes all approvals for label expansions of existing products and reformulations of existing products to select only original product approvals -- including...
IHI: Medical Devices Make a Momentum Comeback
Don Dion submits: In the last few months of tough stock-market sledding, one of the tried-and-true axioms of investing has come to the forefront: The health care sector is a good place to hide during bear markets. Over the last three months (through Aug. 8), seven funds...
The State of Statins and Stents
Mike Huckman submits: Leerink Swann, which specializes in healthcare equities research, is out with a couple of noteworthy surveys--one on the collateral damage to Merck MRK and Schering-Plough's SGP Vytorin this week and the other on drug-coated stents from Abbott Labs ABT, Boston Scientific BSX, Johnson & Johnson JNJ,...
New Analyst Reports for TENET HEALTHCARE CORPORATION, MEDTRONIC INC, BAXTER INTERNATIONAL INC, and ELAN CORP
MaybachFinancial.com is one of the fastest growing independent and unbiased research firms in the world. Through our numerous partnerships with many of the top investment minds in the world, we provide research on companies making a move in the markets. Investors seeking genuine analyst opinions on their investments TENET HEALTHCARE...
Zacks Analyst Blog Highlights: Home Diagnostics, Rite Aid, Johnson & Johnson, Medtronic and Analog Devices
CHICAGO -- Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Home Diagnostics, Inc. (Nasdaq: HDIX), Rite Aid Corp. (NYSE: RAD), Johnson...
Medtronic to Participate in the William Blair Annual Growth Conference
MINNEAPOLIS -- Medtronic, Inc. (NYSE: MDT), the world's leading medical technology company, today announced that it will participate in the William Blair 28th Annual Growth Stock conference on Tuesday, June 17, 2008 in Chicago.
Epilepsy Foundation Honors the Medtronic Foundation for Putting People First
MINNEAPOLIS -- The Epilepsy Foundation honored the Medtronic Foundation today for its ongoing dedication and determination to helping people with chronic neurological conditions. The award was presented by the Epilepsy Foundation's president and CEO, Eric R. Hargis, during a ceremony at Medtronic's world headquarters in Fridley, Minn.
Medtronic Receives FDA Approval for Talent™ Thoracic Stent Graft as Minimally-Invasive Treatment for Aortic Disease
25% More Patients with Aneurysms and Penetrating Ulcers of Thoracic Aorta Now Have Access to Life-Saving Therapy that Avoids Open Surgery
Medtronic to Participate in the Goldman Sachs Health Care Conference
MINNEAPOLIS -- Medtronic, Inc. (NYSE: MDT), the world's leading medical technology company, today announced that it will participate in the Goldman Sachs 29th Annual Global Healthcare conference on Wednesday, June 11, 2008 in Dana Point, Calif.
Boston Scientific Announces Court Decision
NATICK, Mass., May 28 /PRNewswire-FirstCall/ -- Boston Scientific Corporation today announced that a U.S. District Court jury in Marshall, Texas has reached a verdict in a patent infringement suit brought against the Company by Medtronic. Medtronic alleged that certain Boston Scientific balloon catheters and stent delivery systems...
Medtronic Awarded $250 Million Damages in Patent Case against Boston Scientific
Federal jury in Marshall, Texas, finds that Boston Scientific Corporation infringed three patents owned by Medtronic
Medtronic Unit to Pay $75 Million to Settle Whistleblower Medicare Fraud Case
Spinal medical device company Kyphon misled hospitals for profit
Medtronic Inc. F4Q08 (Qtr End 04/25/08) Earnings Call Transcript
Medtronic Inc. F4Q08 (Qtr End 04/25/08) Earnings Call Transcript
Medtronic Annual Revenue up 10 Percent to $13.515 Billion
Fourth Quarter Revenue up 18 Percent to $3.860 Billion
Medtronic Provides Revenue and EPS Guidance for Fiscal Year 2009
MINNEAPOLIS -- Medtronic, Inc. (NYSE: MDT) today provided revenue and diluted earnings per share EPS guidance for fiscal year 2009.
Heart Valve Surgery is Advanced by New Medtronic Repair Device That Uniquely Addresses the Geometry of the Mitral Valve
Profile 3D[TM] Annuloplasty System to Help Increase Mitral Valve Repair;
Medtronic CONNECT Trial Concludes Enrollment
Nationwide Study Examines Role of Remote Patient Monitoring System and Implanted Wireless Cardiac Devices in Improving Patient Care and Reducing Healthcare Costs
- Next »
- page 1 of 57
- « Previous
Sort byClose
View by Content TypeClose
View Related Content by Tag Close
- FDA (71 results)
- patient (63 results)
- stock (52 results)
- Webcast (44 results)
- therapy (33 results)
- board (33 results)
- health care (31 results)
- industry (23 results)
- medical device (20 results)
- clinical trial (17 results)
- dividend (15 results)
- agreement (15 results)
- Biomet Inc. (14 results)
- Johnson & Johnson (14 results)
- physician (12 results)
- New York Stock Exchange (12 results)
- CD (11 results)
- Endeavor (10 results)
- financial (10 results)
- Guidant Corp. (9 results)
- merger (8 results)
- monitoring (8 results)
- talent (8 results)
- Microsoft Windows CE (8 results)
- sales (8 results)
- stock market (8 results)
- Citigroup Inc. (8 results)
- benefit (8 results)
- Allstate Corp. (8 results)
- Boston Scientific Corp. (8 results)
- manufacturing (7 results)
- acquisition (7 results)
- company (7 results)
- blog (7 results)
- wireless (6 results)
- Leadership (6 results)
- ConocoPhillips Co. (6 results)
- Microsoft Access (6 results)
- Healthcare (6 results)
- Goldman Sachs & Co. (6 results)
- Sprint Communications (5 results)
- class action (5 results)
- Internet (5 results)
- network (5 results)
- Abbott Laboratories Inc. (5 results)
- Applied Materials Inc. (5 results)
- alliance (5 results)
- earnings (4 results)
- J.P. Morgan Chase & Co. (4 results)
- Sanford C. Bernstein & Co. (4 results)
- Incorporated: 1957
- CEO: Mr. William A. Hawkins III
Medtronic is a provider of enhanced products and therapies for use by medical professionals to address the healthcare needs of their patients. Co.'s primary products include those for cardiac rhythm disorders, cardiovascular disease, neurological disorders, spinal conditions and musculoskeletal trauma, urological and digestive disorders, diabetes, and ear, nose, and throat conditions. As of Apr 25 2008, Co. conducted its businesses through seven operating segments that manufacture and sell device-based medical therapies: Cardiac Rhythm Disease Management, Spinal, CardioVascular, Neuromodulation, Diabetes, Surgical Technologies, as well as Physio-Control.
Key Competitors
Medtronic Inc. Company Info
Board of Directors
Mr. David L. Calhoun
Dr. Victor J. Dzau M.D.
Ms. Denise M. O'Leary
Mr. James T. Lenehan
Mr. Kendall J. Powell
Mr. Richard H. Anderson
Mr. Robert C. Pozen
Mr. William A. Hawkins III
Dr. Shirley Ann Jackson Ph.D.
Mr. Jean-Pierre Rosso
Mr. Jack W. Schuler
Contact Information
710 Medtronic Parkway
Minneapolis, MN
763 514-4000
NAICS Code
Electromedical and Electrotherapeutic Apparatus Manufacturing: 334510
